Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$74,936.00
Apr 1, 2026
For-profit organization
Improving the Measurement of Retinal Blood Vessel Leakage and Perfusion
1040532
Diseased blood vessels in the retina are the main cause of vision loss in diseases like age-related macular degeneration and diabetic retinopathy, which collectively affect 380 million individuals worldwide. The primary mechanisms that drive vision loss in these diseases are well-known: (i) leakage from retinal blood vessels, and (ii) reduced blood supply to retinal tissue.
The aim is ultimately to develop a robust method for measuring leakage from retinal blood vessels and reduced retinal blood supply, to allow accurate monitoring of these abnormalities during patient follow-up and in response to treatment.
$74,880.00
Oct 1, 2025
For-profit organization
GenFA Training and Testing
1034864
Leaky blood vessels in the retina are the main cause of vision loss in diseases like age-related macular degeneration and diabetic retinopathy – which collectively affect 380 million individuals worldwide. While there are drugs that can stop retinal leakage, the most reliable test for detecting it involves an injection of dye and necessitates emergency readiness in case of an allergic reaction. Hence, this test is invasive, complex, costly, and infrequently used. To address this challenge, we propose an innovative artificial intelligence (AI) approach that will simulate the invasive test from a non-invasive, injection-free photograph commonly collected in routine eye exams.
$100,000.00
Jan 27, 2022
219540
219540
Provide staffing support for the launch of RetiCAD Ocular Analysis Software
$248,729.00
Aug 23, 2021
For-profit organization
Development of AI-based Image Analysis Technology for the Early Diagnosis of Diabetes Retinopathy
977488
The goal of the project is to further the development the Firm's artificial intelligence capabilities and enhance the ability to provide useful analysis from multi-modal data sources in the diagnosis of retinal disorders.
$21,676.00
Dec 20, 2020
For-profit organization
Innovation Assistance Program – Round 2.5
968047
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
$57,704.00
Jun 25, 2020
For-profit organization
Innovation Assistance Program – Round 2
959967
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
$50,000.00
Jun 11, 2020
215036
215036
Engage marketing and regulatory consultants to establish early adopters
$40,656.00
Apr 1, 2020
For-profit organization
Innovation Assistance Program
950135
The funding provided by the IAP program is intended to assist innovative small and medium-sized enterprises in the start-up phase that cannot access existing commercial support related to COVID-19.
$50,000.00
Jul 4, 2019
213753
213753
Engage expertise to develop financial and marketing strategies
$128,445.00
Dec 17, 2018
For-profit organization
Emagix Software System Development
918169
Emagix’s prototype fluorescein angiography software analyses a series of images of the retina to assess the permeability of retinal blood vessels associated with diabetic retinopathy. The objective of this project is to transpose the software from a prototype Matlab environment into a production platform, with commercially viable performance goals.